| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |